Changing therapeutic paradigms for exudative age-related macular degeneration: antiangiogenic agents and photodynamic therapy

Author： Ciulla T.A.   Danis R.P.   Criswell M.   Pratt L.M.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.12, 1999-12, pp. : 2173-2182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on photodynamic therapy in age-related macular degeneration

By Rechtman Ehud   Ciulla Thomas A   Criswell Mark H   Pollack Ayala   Harris Alon  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 931-938

Informa Healthcare

Access to resources Recommend Favorite

Pegaptanib: In Exudative Age-Related Macular Degeneration

By Siddiqui M. Asif A.   Keating Gillian M.  

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1571-1577

Adis International

Access to resources Recommend Favorite

Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration

By Stewart Michael W  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 103-113

Informa Healthcare

Access to resources Recommend Favorite

Current and Future Treatment Options for Nonexudative and Exudative Age-Related Macular Degeneration

By Grant M. Comer  

Drugs & Aging, Vol. 21, Iss. 15, 2004-01 ,pp. : 967-992

Adis International

Access to resources Recommend Favorite

Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration

By Comer Grant M   Ciulla Thomas A   Heier Jeffery S   Criswell Mark H  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 119-135

Informa Healthcare

Access to resources Recommend Favorite